Hurley-Novatny A, Chang D, Murakami K, Wang L, Li H
Front Endocrinol (Lausanne). 2024; 15():1398050.
PMID: 39669499
PMC: 11634624.
DOI: 10.3389/fendo.2024.1398050.
Donen G, Milad N, Bernatchez P
J Neuromuscul Dis. 2023; 10(6):1003-1012.
PMID: 37574742
PMC: 10657711.
DOI: 10.3233/JND-230126.
Schneider H
Front Physiol. 2023; 14:1223278.
PMID: 37324402
PMC: 10262311.
DOI: 10.3389/fphys.2023.1223278.
Uryash A, Mijares A, Esteve E, Adams J, Lopez J
Biomedicines. 2023; 11(2).
PMID: 36831159
PMC: 9953629.
DOI: 10.3390/biomedicines11020623.
Kaplan K, Morgan K
Front Physiol. 2022; 13:1059021.
PMID: 36505053
PMC: 9732661.
DOI: 10.3389/fphys.2022.1059021.
Single cell sequencing maps skeletal muscle cellular diversity as disease severity increases in dystrophic mouse models.
Saleh K, Xi H, Switzler C, Skuratovsky E, Romero M, Chien P
iScience. 2022; 25(11):105415.
PMID: 36388984
PMC: 9646951.
DOI: 10.1016/j.isci.2022.105415.
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the Model of Duchenne Muscular Dystrophy.
Podkalicka P, Mucha O, Kazirod K, Bronisz-Budzynska I, Ostrowska-Paton S, Tomczyk M
Biomedicines. 2021; 9(5).
PMID: 33925757
PMC: 8145677.
DOI: 10.3390/biomedicines9050481.
Cardiovascular phenotype of the rat - a suitable animal model for Duchenne muscular dystrophy.
Szabo P, Ebner J, Koenig X, Hamza O, Watzinger S, Trojanek S
Dis Model Mech. 2021; 14(2).
PMID: 33619211
PMC: 7927653.
DOI: 10.1242/dmm.047704.
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.
White Z, Hakim C, Theret M, Yang N, Rossi F, Cox D
J Clin Lipidol. 2020; 14(4):459-469.e0.
PMID: 32593511
PMC: 7492428.
DOI: 10.1016/j.jacl.2020.05.098.
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress.
Grounds M, Terrill J, Al-Mshhdani B, Duong M, Radley-Crabb H, Arthur P
Dis Model Mech. 2020; 13(2).
PMID: 32224496
PMC: 7063669.
DOI: 10.1242/dmm.043638.
Contribution of TRPC Channels to Intracellular Ca Dyshomeostasis in Smooth Muscle From mdx Mice.
Lopez J, Uryash A, Faury G, Esteve E, Adams J
Front Physiol. 2020; 11:126.
PMID: 32153426
PMC: 7044154.
DOI: 10.3389/fphys.2020.00126.
Targeting angiogenesis in Duchenne muscular dystrophy.
Podkalicka P, Mucha O, Dulak J, Loboda A
Cell Mol Life Sci. 2019; 76(8):1507-1528.
PMID: 30770952
PMC: 6439152.
DOI: 10.1007/s00018-019-03006-7.
Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
Sellers S, Milad N, White Z, Pascoe C, Chan R, Payne G
J Lipid Res. 2017; 59(2):261-272.
PMID: 29175948
PMC: 5794421.
DOI: 10.1194/jlr.M079459.
Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N, White Z, Tehrani A, Sellers S, Rossi F, Bernatchez P
Skelet Muscle. 2017; 7(1):19.
PMID: 28899419
PMC: 5596936.
DOI: 10.1186/s13395-017-0135-9.
Microcirculation in skeletal muscle.
Hudlicka O
Muscles Ligaments Tendons J. 2013; 1(1):3-11.
PMID: 23738238
PMC: 3666465.
Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun J, OBrien R, Song M, Wondrasch B, Berry S
Stem Cells Transl Med. 2013; 2(1):68-80.
PMID: 23283493
PMC: 3659745.
DOI: 10.5966/sctm.2012-0107.
Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS.
Dabire H, Barthelemy I, Blanchard-Gutton N, Sambin L, Carlos Sampedrano C, Gouni V
Basic Res Cardiol. 2011; 107(1):240.
PMID: 22193759
PMC: 3358670.
DOI: 10.1007/s00395-011-0240-6.
Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice.
Baby S, Bogdanovich S, Willmann G, Basu U, Lozynska O, Khurana T
Brain Pathol. 2009; 20(2):323-42.
PMID: 19486009
PMC: 8095546.
DOI: 10.1111/j.1750-3639.2009.00275.x.
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.
Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn J, Yasuhara S
PLoS One. 2007; 2(8):e806.
PMID: 17726536
PMC: 1950086.
DOI: 10.1371/journal.pone.0000806.
Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy.
Narukami H, Yoshioka K, Zhao J, Miike T
Acta Neuropathol. 1991; 81(5):510-6.
PMID: 1858482
DOI: 10.1007/BF00310131.